Wide Ranks

BAX

Baxter International Inc.

33.31

Top Statistics
Market Cap 17 B Forward PE 13.27 Revenue Growth 3.80 %
Current Ratio 1.43 Trailing PE 133.24 Earnings Growth -94.50 %
Profit Margins 0.72 % Peg Ratio Dividend Yield 2.04 %
Enterprice / EBITA 10.51 Enterprise / Revenue 1.92 Price To Sales Trailing12 Months 1.13
Profitability
Profit Margins 0.72 % Operating Margins 8.93 %
Balance Sheet
Total Cash 1 B Total Cash Per Share 2.78 Total Debt 13 B
Total Debt To Equity 166.13 Current Ratio 1.43 Book Value Per Share 15.42
All Measures
Short Ratio 362.00 % Message Board Id finmb_254571 Shares Short Prior Month 12 M
Return On Equity 0.0163 City Deerfield Uuid 6ab3de01-de88-3bf0-be41-5437c59fc509
Previous Close 32.87 First Trade Date Epoch Utc 373 M Book Value 15.42
Beta 0.6040 Total Debt 13 B Volume 3 M
Price To Book 2.16 Last Split Date 1 B Fifty Two Week Low 31.60
Total Cash Per Share 2.78 Total Revenue 15 B Shares Short Previous Month Date 1 B
Target Median Price 38.00 Max Age 86400 Recommendation Mean 2.73
Sand P52 Week Change 0.3133 Operating Margins 8.93 % Last Dividend Value 0.2900
Target Mean Price 40.32 Net Income To Common 121 M Ask 33.32
Short Percent Of Float 0.0328 Implied Shares Outstanding 510 M Last Fiscal Year End 1 B
Trailing Peg Ratio None Average Daily Volume10 Day 5 M Average Volume10days 5 M
Total Cash 1 B Next Fiscal Year End 1 B Revenue Per Share 29.64
Held Percent Insiders 0.0038 Ebitda Margins 18.22 % Dividend Rate 0.6800
Trailing PE 133.24 Date Short Interest 1 B Most Recent Quarter 1 B
Regular Market Previous Close 32.87 Target Low Price 35.00 Gmt Off Set Milliseconds -18000000
Fifty Day Average 35.81 Open 33.15 Dividend Yield 2.04 %
State IL Free Cashflow 102 M Return On Assets 0.0316
Time Zone Short Name EST Trailing Eps 0.2500 Day Low 32.98
Address1 One Baxter Parkway Trailing Annual Dividend Rate 1.16 Price Hint 2
Shares Outstanding 510 M Target High Price 62.00 Website https://www.baxter.com
52 Week Change -0.0768 Average Volume 3 M Earnings Quarterly Growth -94.40 %
Forward Eps 2.88 Recommendation Key hold Compensation As Of Epoch Date 1 B
Quick Ratio 51.70 % Last Split Factor 1841:1000 Regular Market Day High 33.37
Is_sp_500 True Profit Margins 0.72 % Debt To Equity 166.13
Fifty Two Week High 44.01 Day High 33.37 Shares Short 12 M
Regular Market Open 33.15 Industry Key medical-instruments-supplies Bid 33.26
Earnings Growth -94.50 % Enterprise To Revenue 1.92 Revenue Growth 3.80 %
Shares Percent Shares Out 0.0250 Operating Cashflow 1 B Five Year Avg Dividend Yield 195.00 %
Currency USD Market Cap 17 B Time Zone Full Name America/New_York
Is_nasdaq_100 False Zip 60015 Payout Ratio 464.00 %
Quote Type EQUITY Industry Medical Instruments & Supplies Ex Dividend Date 1 B
Regular Market Day Low 32.98 Held Percent Institutions 0.9471 Long Name Baxter International Inc.
Current Price 33.31 Enterprise To Ebitda 10.51 Financial Currency USD
Trailing Annual Dividend Yield 3.53 % Current Ratio 1.43 Gross Margins 37.46 %
Industry Disp Medical Instruments & Supplies Number Of Analyst Opinions 12 Country United States
Float Shares 508 M Two Hundred Day Average 37.29 Ir Website http://investor.baxter.com/phoenix.zhtml?c=86121&p=irol-stockQuoteChart
Enterprise Value 28 B Price To Sales Trailing12 Months 1.13 Forward PE 13.27
Regular Market Volume 3 M Last Dividend Date 1 B Ebitda 2 B
Exchange NYQ
Go to Yahoo Finance Go to Seeking Alpha 
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide.

The company operates through four segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care.

The company offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; generic injectable pharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space, including surgical video technologies, precision positioning devices, and other accessories.

It also provides administrative sets; adhesion prevention products; inhaled anesthesia; drug compounding; chronic and acute dialysis therapies and services, including peritoneal dialysis (PD), hemodialysis (HD), continuous renal replacement therapies (CRRT), and other organ support therapies.

The company's products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors' offices, and patients at home under physician supervision.

The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries.

It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic products; and a collaborative research agreement with Miromatrix Medical Inc. aiming to advance care for patients with acute liver failure.

Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.